Moderna Reaches Agreement with Kenya to Establish its First mRNA Manufacturing Facility in Africa
Moderna (NASDAQ: MRNA) announced Monday that it has established a memorandum of understanding with Kenya to build a covid vaccine manufacturing facility in Africa. The company is building the mRNA plant in Africa with the intention of producing a maximum of 500 million doses of vaccines per year. [stock_market_widget type=”inline-label” template=”basic9″ color=”orange” assets=”MRNA” api=”yf”] [stock_market_widget …